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Abstract Body (358)  
Introduction: 3D-printing technologies are becoming increasingly available to produce medicines when individualization 
of the therapy is required (1). Fused deposition modeling (FDM) is a printing technology, which enables the production 
of tablets with different compositions, shapes and sizes (2). The printer requires the use of a filament prepared in-house 
by hot melt extrusion (HME). The aim of this work was to assess both extrudability and printability of materials, as well 
as the impact of environmental humidity on the characteristics of printed tablets. 
Methods: Six different mixtures of hydroxypropylcellulose, Soluplus®, magnesium stearate and paracetamol were hot-
melt extruded to produce drug-loaded filaments; from these, cylindrical tablets were produced by FDM, according to an 
AutoCad template exported as a stereolithography (.stl) file into Cura. The processing parameters of the printer were set 
at: extrusion temperature (200°C), extrusion rate (20mm/s), printing speed (150mm/s), layer height (0.50mm) and a 
100% infill. 3D-printed tablets were stored in desiccators, at 24°C and different relative humidities (11%, 53%, 75%, 
93%). The tablets were evaluated for thermal properties (DSC), drug content (UV) and dimensions/morphology at 0, 7, 
14 and 30 days of storage. 
Results: Five out of the six formulations considered (Table 1) could be hot-melt extruded to produce filaments and 
subsequently 3D-printed by FDM to produce tablets. Heat during printing has produced amorphous solid dispersions of 
paracetamol in the tablets, as ascertained by the decreased or absent endotherm in DSC thermograms, as compared 
with pure paracetamol. As anticipated, neither mass nor dimensions varied during the period of study. Noteworthy is that 
drug content (Table 1) remained constant and amorphous paracetamol was present throughout the stability study.  
Conclusion: Tablets with adequate characteristics for oral delivery of paracetamol were successfully printed by FDM 
and deemed stable upon storage at different humidities, for 30 days. 
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